Awilda Stapelfeld

583 citations
13 papers · 504 indexed · h-index 11

Awilda Stapelfeld

13 papers receiving 484 citations

Peers

Awilda Stapelfeld
Comparison fields: 5 of 63
  • Molecular Biology 261
  • Cellular and Molecular Neuroscience 227
  • Organic Chemistry 167
  • Physiology 103
  • Pharmacology 85
Replace Lain‐Yen Hu with:
Lain‐Yen Hu United States
Anna Wyrębska Poland
T. Ladduwahetty United States
Dennis Yasuda United States
Vittorio Vecchietti Italy
Kuniaki Kawamura Japan
Lakmal W. Boteju United States
Scott C. Mayer United States
Monique Zreika France
Kerry L. Chapman United Kingdom
Awilda Stapelfeld relative to Lain‐Yen Hu United States Lain‐Yen Hu's profile →
Citations per field
00.5×3.1×
Lain‐Yen Hu · 1×
Citations per year

Countries citing papers authored by Awilda Stapelfeld

Since Specialization
Citations

This map shows the geographic impact of Awilda Stapelfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Awilda Stapelfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Awilda Stapelfeld more than expected).

Fields of papers citing papers by Awilda Stapelfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Awilda Stapelfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Awilda Stapelfeld. The network helps show where Awilda Stapelfeld may publish in the future.

Co-authorship network of co-authors of Awilda Stapelfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Awilda Stapelfeld. A scholar is included among the top collaborators of Awilda Stapelfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Awilda Stapelfeld. Awilda Stapelfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 42
2 57
3 6
4 24
5 63
6 2
7 63
8 83
9 31
10 31
11 14
12 51
13 37

About Awilda Stapelfeld

Awilda Stapelfeld is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Toxicology, having authored 13 papers that have together received 504 indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (7 papers), Neuropeptides and Animal Physiology (7 papers) and Pain Mechanisms and Treatments (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (227 citations), Organic Chemistry (167 citations) and Biochemistry (38 citations). Awilda Stapelfeld has collaborated with scholars based in United States, China and France. Frequent co-authors include Michael A. Savage, Donna L. Hammond, E. Ann Hallinan, Melvin Reichman, Timothy J. Hagen, Edward J. Drower, Michael Rafferty, Ronald C. Haaseth, Henry I. Mosberg and B R de Costa. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026